News and Trends 3 Nov 2022
Trial and new drug for Tourette Syndrome after $250M after funding round completed
A phase 3 clinical trial and the potential commercialization of a new class of drug for patients with Tourette Syndrome have been funded after an upsized and oversubscribed $250 million…